Cargando…

Anti-inflammatory HDL effects are impaired in atrial fibrillation

High-density lipoprotein (HDL), best known for cholesterol transport, also has anti-inflammatory effects. Previous studies suggest involvement of myeloperoxidase (MPO) in modification of HDL. HDL bound Sphingosine-1-phosphate (S1P) has been implied to be an essential protein regarding beneficial HDL...

Descripción completa

Detalles Bibliográficos
Autores principales: Holzwirth, Erik, Fischer-Schaepmann, Tina, Obradovic, Danilo, von Lucadou, Mirjam, Schwedhelm, Edzard, Daum, Günter, Hindricks, Gerhard, Marsche, Gunther, Trieb, Markus, Thiele, Holger, Kornej, Jelena, Büttner, Petra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732851/
https://www.ncbi.nlm.nih.gov/pubmed/34459957
http://dx.doi.org/10.1007/s00380-021-01908-w
_version_ 1784627688424603648
author Holzwirth, Erik
Fischer-Schaepmann, Tina
Obradovic, Danilo
von Lucadou, Mirjam
Schwedhelm, Edzard
Daum, Günter
Hindricks, Gerhard
Marsche, Gunther
Trieb, Markus
Thiele, Holger
Kornej, Jelena
Büttner, Petra
author_facet Holzwirth, Erik
Fischer-Schaepmann, Tina
Obradovic, Danilo
von Lucadou, Mirjam
Schwedhelm, Edzard
Daum, Günter
Hindricks, Gerhard
Marsche, Gunther
Trieb, Markus
Thiele, Holger
Kornej, Jelena
Büttner, Petra
author_sort Holzwirth, Erik
collection PubMed
description High-density lipoprotein (HDL), best known for cholesterol transport, also has anti-inflammatory effects. Previous studies suggest involvement of myeloperoxidase (MPO) in modification of HDL. HDL bound Sphingosine-1-phosphate (S1P) has been implied to be an essential protein regarding beneficial HDL effects. In this study, we analyzed anti-inflammatory HDL properties in patients with atrial fibrillation (AF), a disease involving atrial inflammation, compared to non-AF controls and whether anti-inflammatory properties improve upon catheter ablation. Additionally, association with serum concentrations of MPO and S1P were assessed. We isolated HDL from 25 AF patients, 13 non-AF individuals and 14 AF patients at follow-up (FU) after catheter ablation. S1P was measured in a cohort of 141 AF and 21 FU patients. Following preincubation with HDL from either group, bovine aortic endothelial cells were stimulated using tumor necrosis factor α and expression of pro-inflammatory genes intercellular adhesion molecule 1 (ICAM1), vascular cell adhesion molecule 1 (VCAM1), E-selectin (SELE) and P-selectin (SELP) was assessed using qPCR. Concentrations of circulating protein of these genes as well as MPO and S1P were measured in serum samples. Compared to non-AF individuals HDL from AF patients suppressed gene expression of the pro-inflammatory adhesion molecules ICAM1, VCAM1, SELE and SELP 27%, 18%, 21% and 57% less, respectively (p < 0.05 for all except SELE p = 0.06). In FU patients, the anti-inflammatory HDL activity was improved (suppression of ICAM1 + 22%, VCAM1 + 10%, SELE + 38% and SELP + 75%, p < 0.05 for all except VCAM1 p = 0.08). AF patients using angiotensin converting enzyme inhibitors or angiotensin receptor blockers had better anti-inflammatory HDL properties than non-users (gene expression suppression at least 28% more, p < 0.05 for all except ICAM1 p = 0.051). Circulating protein concentrations were not correlated with in vitro gene-expression, but circulating P-selectin was generally elevated in AF and FU patients compared to non-AF patients. MPO plasma concentration was positively associated with gene-expression of ICAM1, VCAM1 and SELP (r(2) > 0.4, p < 0.05). Serum concentrations of S1P were increased in FU patients {1.201 µM [1.077–1.543]} compared to AF patients {0.953 µM [0.807–1.135], p < 0.01} but not correlated with ICAM1, VCAM1 and SELP gene expression. We conclude that the anti-inflammatory activity of HDL is impaired in AF patients, which might promote AF progression and AF-associated complications. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00380-021-01908-w.
format Online
Article
Text
id pubmed-8732851
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-87328512022-01-18 Anti-inflammatory HDL effects are impaired in atrial fibrillation Holzwirth, Erik Fischer-Schaepmann, Tina Obradovic, Danilo von Lucadou, Mirjam Schwedhelm, Edzard Daum, Günter Hindricks, Gerhard Marsche, Gunther Trieb, Markus Thiele, Holger Kornej, Jelena Büttner, Petra Heart Vessels Original Article High-density lipoprotein (HDL), best known for cholesterol transport, also has anti-inflammatory effects. Previous studies suggest involvement of myeloperoxidase (MPO) in modification of HDL. HDL bound Sphingosine-1-phosphate (S1P) has been implied to be an essential protein regarding beneficial HDL effects. In this study, we analyzed anti-inflammatory HDL properties in patients with atrial fibrillation (AF), a disease involving atrial inflammation, compared to non-AF controls and whether anti-inflammatory properties improve upon catheter ablation. Additionally, association with serum concentrations of MPO and S1P were assessed. We isolated HDL from 25 AF patients, 13 non-AF individuals and 14 AF patients at follow-up (FU) after catheter ablation. S1P was measured in a cohort of 141 AF and 21 FU patients. Following preincubation with HDL from either group, bovine aortic endothelial cells were stimulated using tumor necrosis factor α and expression of pro-inflammatory genes intercellular adhesion molecule 1 (ICAM1), vascular cell adhesion molecule 1 (VCAM1), E-selectin (SELE) and P-selectin (SELP) was assessed using qPCR. Concentrations of circulating protein of these genes as well as MPO and S1P were measured in serum samples. Compared to non-AF individuals HDL from AF patients suppressed gene expression of the pro-inflammatory adhesion molecules ICAM1, VCAM1, SELE and SELP 27%, 18%, 21% and 57% less, respectively (p < 0.05 for all except SELE p = 0.06). In FU patients, the anti-inflammatory HDL activity was improved (suppression of ICAM1 + 22%, VCAM1 + 10%, SELE + 38% and SELP + 75%, p < 0.05 for all except VCAM1 p = 0.08). AF patients using angiotensin converting enzyme inhibitors or angiotensin receptor blockers had better anti-inflammatory HDL properties than non-users (gene expression suppression at least 28% more, p < 0.05 for all except ICAM1 p = 0.051). Circulating protein concentrations were not correlated with in vitro gene-expression, but circulating P-selectin was generally elevated in AF and FU patients compared to non-AF patients. MPO plasma concentration was positively associated with gene-expression of ICAM1, VCAM1 and SELP (r(2) > 0.4, p < 0.05). Serum concentrations of S1P were increased in FU patients {1.201 µM [1.077–1.543]} compared to AF patients {0.953 µM [0.807–1.135], p < 0.01} but not correlated with ICAM1, VCAM1 and SELP gene expression. We conclude that the anti-inflammatory activity of HDL is impaired in AF patients, which might promote AF progression and AF-associated complications. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00380-021-01908-w. Springer Japan 2021-08-30 2022 /pmc/articles/PMC8732851/ /pubmed/34459957 http://dx.doi.org/10.1007/s00380-021-01908-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Holzwirth, Erik
Fischer-Schaepmann, Tina
Obradovic, Danilo
von Lucadou, Mirjam
Schwedhelm, Edzard
Daum, Günter
Hindricks, Gerhard
Marsche, Gunther
Trieb, Markus
Thiele, Holger
Kornej, Jelena
Büttner, Petra
Anti-inflammatory HDL effects are impaired in atrial fibrillation
title Anti-inflammatory HDL effects are impaired in atrial fibrillation
title_full Anti-inflammatory HDL effects are impaired in atrial fibrillation
title_fullStr Anti-inflammatory HDL effects are impaired in atrial fibrillation
title_full_unstemmed Anti-inflammatory HDL effects are impaired in atrial fibrillation
title_short Anti-inflammatory HDL effects are impaired in atrial fibrillation
title_sort anti-inflammatory hdl effects are impaired in atrial fibrillation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732851/
https://www.ncbi.nlm.nih.gov/pubmed/34459957
http://dx.doi.org/10.1007/s00380-021-01908-w
work_keys_str_mv AT holzwirtherik antiinflammatoryhdleffectsareimpairedinatrialfibrillation
AT fischerschaepmanntina antiinflammatoryhdleffectsareimpairedinatrialfibrillation
AT obradovicdanilo antiinflammatoryhdleffectsareimpairedinatrialfibrillation
AT vonlucadoumirjam antiinflammatoryhdleffectsareimpairedinatrialfibrillation
AT schwedhelmedzard antiinflammatoryhdleffectsareimpairedinatrialfibrillation
AT daumgunter antiinflammatoryhdleffectsareimpairedinatrialfibrillation
AT hindricksgerhard antiinflammatoryhdleffectsareimpairedinatrialfibrillation
AT marschegunther antiinflammatoryhdleffectsareimpairedinatrialfibrillation
AT triebmarkus antiinflammatoryhdleffectsareimpairedinatrialfibrillation
AT thieleholger antiinflammatoryhdleffectsareimpairedinatrialfibrillation
AT kornejjelena antiinflammatoryhdleffectsareimpairedinatrialfibrillation
AT buttnerpetra antiinflammatoryhdleffectsareimpairedinatrialfibrillation